Projection of top orphan drugs by global revenue 2028
This statistic displays a projection of the leading 10 global orphan drugs based on revenues in 2028. For that year, it is projected that AbbVie's Venclexta will generate some 3.3 billion U.S. dollars in revenue. Orphan drugs are used to target rare diseases or disorders, which in the United States is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the United States through the Orphan Drug Act of 1983.